223 related articles for article (PubMed ID: 28446503)
1. Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer.
Rosenthal EL; Moore LS; Tipirneni K; de Boer E; Stevens TM; Hartman YE; Carroll WR; Zinn KR; Warram JM
Clin Cancer Res; 2017 Aug; 23(16):4744-4752. PubMed ID: 28446503
[No Abstract] [Full Text] [Related]
2. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.
Voskuil FJ; de Jongh SJ; Hooghiemstra WTR; Linssen MD; Steinkamp PJ; de Visscher SAHJ; Schepman KP; Elias SG; Meersma GJ; Jonker PKC; Doff JJ; Jorritsma-Smit A; Nagengast WB; van der Vegt B; Robinson DJ; van Dam GM; Witjes MJH
Theranostics; 2020; 10(9):3994-4005. PubMed ID: 32226534
[TBL] [Abstract][Full Text] [Related]
4. Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.
Gao RW; Teraphongphom N; de Boer E; van den Berg NS; Divi V; Kaplan MJ; Oberhelman NJ; Hong SS; Capes E; Colevas AD; Warram JM; Rosenthal EL
Theranostics; 2018; 8(9):2488-2495. PubMed ID: 29721094
[No Abstract] [Full Text] [Related]
5. Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study.
Lu G; van den Berg NS; Martin BA; Nishio N; Hart ZP; van Keulen S; Fakurnejad S; Chirita SU; Raymundo RC; Yi G; Zhou Q; Fisher GA; Rosenthal EL; Poultsides GA
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):753-764. PubMed ID: 32416764
[TBL] [Abstract][Full Text] [Related]
6. Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW.
Krishnan G; van den Berg NS; Nishio N; Juniper G; Pei J; Zhou Q; Lu G; Lee YJ; Ramos K; Iagaru AH; Baik FM; Colevas AD; Martin BA; Rosenthal EL
Theranostics; 2021; 11(15):7188-7198. PubMed ID: 34158844
[No Abstract] [Full Text] [Related]
7. Effect of Formalin Fixation for Near-Infrared Fluorescence Imaging with an Antibody-Dye Conjugate in Head and Neck Cancer Patients.
Kapoor S; Lu G; van den Berg NS; Krishnan G; Pei J; Zhou Q; Martin BA; Baik FM; Rosenthal EL; Nishio N
Mol Imaging Biol; 2021 Apr; 23(2):270-276. PubMed ID: 33078373
[TBL] [Abstract][Full Text] [Related]
8. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
[TBL] [Abstract][Full Text] [Related]
9. The Sentinel Margin: Intraoperative
van Keulen S; Nishio N; Birkeland A; Fakurnejad S; Martin B; Forouzanfar T; Cunanan K; Colevas AD; S van den Berg N; Rosenthal E
Clin Cancer Res; 2019 Aug; 25(15):4656-4662. PubMed ID: 31142505
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant anti-angiogenic therapy enhances chemotherapeutic uptake in a murine model of head and neck cancer
Prince AC; Patel NG; Moore LS; McGee AS; Ahn JC; Willey CD; Carroll WR; Rosenthal EL; Warram JM
J Drug Target; 2019 Feb; 27(2):193-200. PubMed ID: 29972342
[TBL] [Abstract][Full Text] [Related]
11. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
12. Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.
Rosenthal EL; Warram JM; de Boer E; Chung TK; Korb ML; Brandwein-Gensler M; Strong TV; Schmalbach CE; Morlandt AB; Agarwal G; Hartman YE; Carroll WR; Richman JS; Clemons LK; Nabell LM; Zinn KR
Clin Cancer Res; 2015 Aug; 21(16):3658-66. PubMed ID: 25904751
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy.
Civantos FJ; Moffat FL; Goodwin WJ
Laryngoscope; 2006 Mar; 112(3 Pt 2 Suppl 109):1-15. PubMed ID: 16540925
[TBL] [Abstract][Full Text] [Related]
14. Epidermal Growth Factor Receptor-Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer.
Vonk J; de Wit JG; Voskuil FJ; Tang YH; Hooghiemstra WTR; Linssen MD; van den Broek E; Doff JJ; de Visscher SAHJ; Schepman KP; van der Vegt B; van Dam GM; Witjes MJH
J Nucl Med; 2022 May; 63(5):672-678. PubMed ID: 34531264
[TBL] [Abstract][Full Text] [Related]
15. The node-negative neck: accuracy of clinical intraoperative lymph node assessment for metastatic disease in head and neck cancer.
Finn S; Toner M; Timon C
Laryngoscope; 2002 Apr; 112(4):630-3. PubMed ID: 12150514
[TBL] [Abstract][Full Text] [Related]
16. Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer.
Tummers WS; Miller SE; Teraphongphom NT; van den Berg NS; Hasan A; Longacre TA; Fisher GA; Bonsing BA; Vahrmeijer AL; Gambhir SS; Swijnenburg RJ; Rosenthal EL; Poultsides GA
HPB (Oxford); 2019 Jul; 21(7):883-890. PubMed ID: 30723062
[TBL] [Abstract][Full Text] [Related]
17. Identification of metastatic nodal disease in a phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non-small cell lung cancer using near-infrared imaging.
Gilmore DM; Khullar OV; Jaklitsch MT; Chirieac LR; Frangioni JV; Colson YL
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):562-70; discussion 569-70. PubMed ID: 23790404
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Diagnostic Accuracy of Baseline Clinical Examination and Ultrasonographic Imaging for the Detection of Lymph Node Metastasis in Patients With High-risk Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Tokez S; Koekelkoren FHJ; Baatenburg de Jong RJ; Grünhagen DJ; Mooyaart AL; Nijsten T; van der Lugt A; Wakkee M
JAMA Dermatol; 2022 Feb; 158(2):151-159. PubMed ID: 34964807
[TBL] [Abstract][Full Text] [Related]
19. Role of near-infrared fluorescence imaging in the resection of metastatic lymph nodes in an optimized orthotopic animal model of HNSCC.
Atallah I; Milet C; Quatre R; Henry M; Reyt E; Coll JL; Hurbin A; Righini CA
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Dec; 132(6):337-42. PubMed ID: 26409829
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic accuracy of 3.0T high-resolution MRI for assessment mesorectal lymph node metastases in patients with rectal cancer].
Chen Y; Yang X; Lu B; Xiao X; Zhuang X; Yu S
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jul; 21(7):786-792. PubMed ID: 30051447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
